NCT06075693View on ClinicalTrials.gov

Cerebrospinal Fluid Biomarkers of Myotonic Dystrophy

RecruitingOBSERVATIONAL

Enrollment

88

Participants

Timeline

Start Date

August 1, 2022

Primary Completion Date

August 1, 2027

Study Completion Date

August 1, 2028

Conditions

Myotonic Dystrophy Type 1

Trial Locations (1)

02129

RECRUITING

Massachusetts General Hospital, Boston

All Listed Sponsors

lead

Massachusetts General Hospital

OTHER